Moderna, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Moderna, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Moderna, Inc. stocks after a simple registration process. </div>

Q: How to buy Moderna, Inc. shares in India?

<div> To buy Moderna, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Moderna, Inc. and you are done!</div> </div>

Q: What is the share price of Moderna, Inc.?

<div>The share price of Moderna, Inc. is USD 125.59 as on 2 May.</div>

Q: What is the Market Capitalization of Moderna, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Moderna, Inc. is USD 48.09B as on 2 May.</div>

Q: What is the PE ratio of Moderna, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Moderna, Inc. is -9.05 as on 2 May. </div>

Q: Is Moderna, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Moderna, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Moderna, Inc. operate?

<div> Moderna, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$125.59

+14.13

(2 May)

Loading Chart

Previous close

$125.59

Open

$125.59

Today’s high

$128.81

Today’s low

$114.06

52W low

$62.55

52W high

$142.79

-4.41%

34.64%

-9.05

EPS (TTM)

-12.34

Shares O/S

382.88M

Market cap

48.09B

Insights

MRNA price is above its 200 day moving average

MRNA PE is in the top end of its range over the past 2 years

In beta. Send feedback here.

Compare with other stock

About Moderna, Inc.

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases.

Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others. .

FAQs

Can I buy Moderna, Inc. shares in India?

How to buy Moderna, Inc. shares in India?

What is the share price of Moderna, Inc.?

What is the Market Capitalization of Moderna, Inc.?

What is the PE ratio of Moderna, Inc.?

Is Moderna, Inc. a good stock to buy?

In which sector / industry does Moderna, Inc. operate?